Vensana Capital Overview
Founded in 2019, Vensana Capital focuses on investing in development and commercial stage companies across the medtech sector, including medical devices, diagnostics, drug delivery, digital health, life science tools, and tech-enabled services. The firm has approximately $1 billion in capital under management and has partnered with over 20 companies, achieving six exits totaling nearly $3 billion in value.
Is Vensana Capital the right investor for your startup? Browse their investment focus, stage preferences, and geographic scope to see how well they align with your fundraising goals. Your full match score with Vensana Capital, along with a list of other relevant VCs, is available on Hopohopo.io.
Vensana Capital
Investment focus
Invest in
- North America 1 / 5
Product type
- Software
- Hardware
- Software-enabled hardware
- Services
Industries / verticals
- Digital & Consumer health
- Health Data, Healthcare Systems & Infrastructure
- MedTech & Devices
Investment role
Lead and follow
Stages
Series A, Series B or later
First ticket size
US$15,000,000 - US$50,000,000
Contact information
Co-founder and Managing Partner
Justin Klein
Investment Professional
Allison King
Investment Professional
Petra Gorombei
How to approach funds like Vensana Capital
When engaging Vensana Capital, founders should highlight clear clinical and commercial validation, as well as a robust pathway to regulatory and market adoption. Emphasize differentiated technology or business models that address significant unmet needs and demonstrate scalability within the medtech ecosystem. Vensana values teams with deep sector expertise and a track record of execution, so showcasing experienced leadership and strategic partnerships can be particularly compelling.
Find the best-fitting investors for your startup
Stop wasting weeks searching for the right investors. Upload your deck and get matched with investors who actually fit your startup — so you can focus on building, not chasing.
